{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:48:23Z","timestamp":1770508103042,"version":"3.49.0"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TCRM"],"DOI":"10.2147\/tcrm.s6382","type":"journal-article","created":{"date-parts":[[2010,9,10]],"date-time":"2010-09-10T00:18:36Z","timestamp":1284077916000},"page":"103","source":"Crossref","is-referenced-by-count":3,"title":["Role of eslicarbazepine in the treatment of epilepsy in adult patients with partial-onset seizures"],"prefix":"10.2147","author":[{"given":"Rifaat","family":"El-Mallakh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2010,3]]},"container-title":["Therapeutics and Clinical Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=5899","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T17:59:11Z","timestamp":1477850351000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/role-of-eslicarbazepine-in-the-treatment-of-epilepsy-in-adult-patients-peer-reviewed-article-TCRM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/tcrm.s6382","relation":{},"ISSN":["1178-203X"],"issn-type":[{"value":"1178-203X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}